Stockscreener 앱 받기
3.05
0.66%
0.02
시간 외 거래:
3.09
0.04
+1.31%
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
What analysts say about Aptevo Therapeutics Inc. stockFree Capital Growth Strategies - jammulinksnews.com
Aptevo Therapeutics Inc. Stock Analysis and ForecastSuperior trading gains - Autocar Professional
What drives Aptevo Therapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com
Is Aptevo Therapeutics Inc. a good long term investmentOutstanding investment returns - jammulinksnews.com
Aptevo Meets Nasdaq $2.5M Equity Requirement - MSN
What makes Aptevo Therapeutics Inc. stock price move sharplyFree Access to Community - Newser
Why Aptevo Therapeutics Inc. stock attracts strong analyst attentionFree Elite Traders Group - Newser
How Aptevo Therapeutics Inc. stock performs during market volatility2x 3x 5x Pick Alert - Newser
10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey
Aptevo regains Nasdaq compliance following $15.9 million equity raise By Investing.com - Investing.com India
Aptevo Therapeutics Regains Nasdaq Compliance with Equity Raise - TipRanks
Aptevo regains Nasdaq compliance following $15.9 million equity raise - Investing.com
Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance - TipRanks
Aptevo (APVO) appoints Baker Tilly as auditor after Moss Adams merger - Stock Titan
Aptevo Therapeutics' 18.7% Plunge: What Drives a Volatile Day Without News? - AInvest
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous - Benzinga
Aptevo (APVO) appoints Baker Tilly as auditor after Moss Adams merger | C SEC FilingForm 424B2 - Stock Titan
Aptevo Therapeutics Surges 82% Amid No Fundamental News—What’s Driving the Spike? - AInvest
Top Small Cap Stocks Worth WatchingJune 18th - MarketBeat
Crude Oil Moves Higher; US Weekly Jobless Claims Decline - Benzinga
Aptevo Therapeutics raises $8 million in registered direct offering - Investing.com Australia
Dow Surges 150 Points; Korn Ferry Earnings Top Views - Benzinga
Aptevo Therapeutics (APVO) Secures $8M Through Direct Offering - GuruFocus
Aptevo Therapeutics announces $8M at-the-market equity offering with warrants; shares more than double - MSN
Aptevo Therapeutics raises $8 million in registered direct offering By Investing.com - Investing.com India
Why Is Micro-Cap Aptevo Stock Trading Higher On Wednesday?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga
Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules | APVO Stock News - GuruFocus
An early stage 85% remissions rate in AML drives Aptevo’s stock surge - BioWorld MedTech
Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules - ACCESS Newswire
Aptevo Secures $8M Funding: Biotech Company Accelerates Cancer Drug Development Pipeline - Stock Titan
Aptevo Therapeutics stock soars after impressive AML treatment results - Investing.com
Aptevo Therapeutics stock soars after impressive AML treatment results By Investing.com - Investing.com Canada
Why did Aptevo Therapeutics Shares Skyrocket in Premarket Trading Today? - Tokenist
Aptevo Therapeutics Skyrockets on Game-Changing AML Drug News - RagingBull
Aptevo reports 85% remission rate in frontline AML trial By Investing.com - Investing.com Nigeria
Aptevo Therapeutics (APVO) Shows Promising Results in RAINIER Tr - GuruFocus
Aptevo Says Its Mipletamig Therapy Achieves 85% Remission Rate in Leukemia Patients; Shares Soar Pre-Bell - MarketScreener
Aptevo Therapeutics (APVO) Shows Promising Results in AML Trial - GuruFocus
Aptevo Therapeutics announces new clinical data from RAINIER trial - TipRanks
Aptevo announces clinical data from ongoing Phase 1b/2 RAINIER trial - TipRanks
Breakthrough AML Drug Achieves 85% Remission Rate: New Hope for Previously Untreatable Patients - Stock Titan
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML | APVO Stock News - GuruFocus
Aptevo Therapeutics Signs Equity Purchase Agreement - TipRanks
APVO Secures Roth Capital Partners as Exclusive Placement Agent - GuruFocus
Short Interest in Aptevo Therapeutics Inc. (NASDAQ:APVO) Decreases By 55.0% - Defense World
0.87%
0.17%
자본화:
|
볼륨(24시간):